标签归档 武汉品茶上课

General Secretary of the Supreme Leader stressed, "Expand foreign trade, cultivate new trade formats and new models, and promote the construction of a trade power." The outline of the 14th Five-Year Plan clearly puts forward "promoting the coordinated development of import and export", requiring "expanding the import of high-quality consumer goods, advanced technology, important equipment and energy resources", "optimizing the quality and structure of export commodities" and "guiding enterprises to deepen traditional export markets and expand emerging markets".

In the first year of the 14 th Five-Year Plan, the quality of China’s foreign trade has increased, achieving a good start.

"This is our latest CNC precision machining center, where raw materials go in and come out as finished products. The precision of holes and screws can be one percent of that of hair. " Hu Lijun, general manager of Zhejiang Cixi Boli Vehicle Co., Ltd. said that since this year, the production line has not stopped, and the order has been scheduled for April 2023.

Boli car owners want to produce high-grade bicycle brake systems, and the products are sold to Europe and South America. Affected by the COVID-19 epidemic, some countries encouraged people to travel by bike, which greatly increased the demand for bicycles. Now the company is running at full capacity, with a monthly output of 150,000 pieces, which still cannot meet the demand of foreign markets. The company’s output value last year was about 150 million yuan, and it is expected to exceed 200 million yuan this year.

"Grasping the current foreign trade business opportunities has benefited from the company’s continuous investment in product research and development and technological transformation in recent years." Hu Lijun said, "We invest more than 50% of our annual profits in research and development. Since last year, the company has invested more than 30 million yuan to transform equipment, reducing the product error rate to about one thousandth, which is at the leading level in the industry. "

According to the data released by the General Administration of Customs, in the first quarter, the total import and export value of China’s goods trade was 8.47 trillion yuan, an increase of 29.2% over the same period last year. Among them, exports were 4.61 trillion yuan, an increase of 38.7%; Imports reached 3.86 trillion yuan, up by 19.3%. In the first quarter, China’s import and export scale not only far exceeded the same period of last year, but also increased by 25.3% and 20.5% respectively compared with the same period of 2018 and 2019.

Foreign trade connects international and domestic markets and resources; The improvement of foreign trade can better smooth the domestic circulation, promote the domestic and international double circulation, and provide strong support for building a new development pattern.

Fill it up and cheer up. In the first year, the commerce, customs and other departments and localities conscientiously implemented the outline of the 14th Five-Year Plan, sought impetus from reform, sought vitality from innovation, actively responded to various unstable and uncertain factors in the international market, promoted the steady and high-quality development of foreign trade.

-expanding high-quality imports to meet domestic demand.

Hainan Duty Free Shop is popular! From February 11 to 17 this year, the sales of Hainan Island Duty Free Shop during the Spring Festival Golden Week in 7 days exceeded 1.5 billion yuan, which was fully doubled compared with the Spring Festival holiday in 2019.

In the middle of last year, the Ministry of Finance, the General Administration of Customs and the State Administration of Taxation issued an announcement to increase the duty-free shopping quota for tourists from outlying islands in Hainan to meet the demand for consumption upgrading. In 2021, all localities and departments will further reduce institutional costs, continue to expand imports of high-quality consumer goods, and promote diversification of import sources. At the same time, with the sustained and stable recovery of China’s economy, we will actively promote the import of high-tech products and energy and other basic materials. Customs data show that in the first quarter, China imported 155.27 billion integrated circuits, an increase of 33.6%; 139 million tons of crude oil, up by 9.5%; 1.436 million tons of copper, an increase of 11.7%.

-optimizing the commodity structure and increasing the added value of exports.

"We seized the consumer’s demand for home entertainment and launched new products with intelligent interaction and voice shopping functions, which suddenly became a fire in overseas markets!" The relevant person in charge of a technology company in Shenzhen said, "In the first two months of this year, the company’s exports reached 30 million US dollars. Electromechanical products such as smart speakers, vacuum cleaners, coffee machines, and electric hair clipper are highly sought after. "

This year, the Ministry of Commerce proposed to focus on the implementation of three major plans: excellent import and export, trade industry integration and smooth trade to ensure the stability and smoothness of the foreign trade industrial chain and supply chain; The General Administration of Customs has taken various measures to optimize supervision services and promote trade facilitation; The vast number of foreign trade enterprises highlight the core competitiveness of technology, brand and service, strive to optimize the quality and structure of export commodities, and cultivate new advantages in export competition. In the first quarter, China exported 2.78 trillion yuan of mechanical and electrical products, up 43%, accounting for 60.3% of the total export value, up 1.7 percentage points over the same period last year; Among them, the export of automatic data processing equipment and its parts, mobile phones and automobiles (including chassis) increased by 54.5%, 38.5% and 98.9% respectively.

-expanding emerging markets and enhancing the ability to resist risks.

Recently, 100 boxes of crisp dates with local characteristics produced and processed by Hebei Huanghua Tiantian Food Development Company were officially loaded and shipped, and sold to Brunei, a country along the Belt and Road Initiative, for the first time. "In the prevention and control of the epidemic, the relevant departments took the initiative to serve and visited the company many times to help us successfully explore new markets and stabilize foreign trade orders." The relevant person in charge of the company said.

At the beginning of this year, the Ministry of Commerce proposed the development of "Silk Road E-commerce", promoted the integration and development of new formats and new models such as cross-border e-commerce and jointly built the "Belt and Road", and added new momentum to the construction of trade corridors such as China-Europe trains and new land and sea passages. All localities, departments and related enterprises have further expanded the "friend circle" of economic and trade cooperation and continuously deepened economic and trade cooperation with countries along the "Belt and Road". In the first quarter, China imported and exported 2.5 trillion yuan to countries along the Belt and Road, an increase of 21.4%. Among them, imports and exports to Vietnam, Indonesia and Poland all achieved rapid growth.

-building an open highland and accelerating the development of new formats.

Not long ago, in Linyi Comprehensive Bonded Zone, Shandong Province, a batch of bonded R&D goods such as single-cell second-generation gel bead kits successfully entered the zone under the supervision of Linyi Customs, becoming the first bonded R&D project of genetic testing in Shandong Comprehensive Bonded Zone. "According to preliminary estimates, through bonded R&D business every year, light-related taxes can save hundreds of thousands of yuan, and our R&D motivation is stronger!" The person in charge of Shandong Kaihua Health Industry Company said.

Since the beginning of this year, the General Administration of Customs, together with relevant departments, has continuously expanded the policy functions of the comprehensive bonded zone, supported the construction of processing and manufacturing centers, R&D and design centers and logistics distribution centers, and accelerated the construction of a new highland for opening to the outside world. The Ministry of Commerce refines service measures, promotes enterprises in the cross-border e-commerce comprehensive test zone to integrate the whole chain of import, transaction and after-sales, and develops new foreign trade models and formats. All localities take the comprehensive bonded zone and cross-border e-commerce comprehensive test zone as platforms, actively attract leading enterprises to enter the zone, and drive the surrounding areas to gather upstream and downstream supporting enterprises. In the first quarter, the import and export of comprehensive bonded zone increased by 41.1%, the import and export of free trade pilot zone increased by 28.4%, and the import of duty-free goods in Hainan Free Trade Port increased by 162.5%.

"In the first quarter, China’s foreign trade achieved a high growth rate that has not been seen for many years, showing the strong resilience and vitality of China’s foreign trade." Liang Ming, director of the Foreign Trade Research Institute of the Research Institute of the Ministry of Commerce, said that it is necessary to scientifically analyze the foreign trade situation, correctly treat the fundamentals of foreign trade, seize opportunities and meet challenges, and promote the "good start" of foreign trade to become a year-round red and sustained red, so as to make greater contributions to speeding up the construction of a new development pattern with domestic macro-cycle as the main body and domestic and international dual-cycle promoting each other.(Reporter Du Haitao, Kelly, Gu Chun, Qi Zhiming, Luo Shanshan)

Source | Cybertron Author | Xiao Wan

The varieties of 42 enterprises passed the consistency evaluation, among which Huahai Pharmaceutical, Unacon and Yangzijiang Pharmaceutical were the top three, followed by Hengrui Pharma, Jingxin Pharmaceutical, Haosen Pharmaceutical and Zhengda Tianqing.

42 pharmaceutical companies have reviewed varieties.

Now in mid-November, the overall progress of consistency evaluation has become the most concerned topic for all pharmaceutical companies. A few days ago, according to the incomplete statistics of CyberBlue, a total of 107 product specifications passed the consistency evaluation, among which 42 enterprises passed the consistency evaluation (the number of branches passed was included in the head office).

In statistics, one product specification of 18 pharmaceutical companies passed the consistency evaluation; Two of the 10 pharmaceutical companies have passed the consistency evaluation; Three varieties of seven pharmaceutical companies have been evaluated; Four varieties of three pharmaceutical companies have been reviewed; Four pharmaceutical companies have more than five product specifications.

(Source: Cyberblue)

Among them, Zhejiang Huahai Pharmaceutical Co., Ltd. passed the consistency evaluation, while Yangzijiang Pharmaceutical Co., Ltd. and Unacon Co., Ltd. passed the consistency evaluation, and Hengrui Pharma Co., Ltd. passed the consistency evaluation. Zhejiang Jingxin Pharmaceutical, Haosen Pharmaceutical and Zhengda Tianqing all passed the consistency evaluation.

The consistency evaluation of Zhejiang Huahai Pharmaceutical, Yangzijiang Pharmaceutical and Unacon has made rapid progress.

(Source: Cyberblue)

Huahai Pharmaceutical Co., Ltd.: Consistency Evaluation of Overtaking in Curves

According to the annual report of Huahai Pharmaceutical, Huahai Pharmaceutical has invested more in the over-evaluation research and development of irbesartan tablets, fosinopril tablets, lisinopril tablets and losartan potassium tablets.

The annual report shows that in 2017, the company’s R&D expenditure was 438.2377 million yuan, a year-on-year increase of 20.38%, accounting for 8.76% of the operating income of that year. The main reason is that the company has continuously increased the declaration and conformity evaluation of domestic new products, increased the R&D investment in biopharmaceuticals, new drugs, first imitation drugs, innovative pharmaceutical preparations, and accelerated the declaration of new products and models in markets such as the United States and the European Union.

Compared with other enterprises with more varieties, Huahai Pharmaceutical is characterized by adopting the form of "overtaking in corners"

—— Its overseas drugs with quality regulations enter the domestic market through supplementary application for domestic listed varieties and direct application for four kinds of new drugs overseas, and only need to BE declared with overseas listed test data, which will greatly reduce the cost and time of declaration compared with similar products enterprises that need to do BE experiments in China.

For example, its valsartan tablet is the first oral preparation of Huahai Pharmaceutical, which has been listed in Europe and America, and it is deemed to have passed the consistency evaluation if it is declared with overseas data.

Cebolan made statistics on the disclosure announcement of Huahai Pharmaceutical. Except for its product "Voriconazole Tablets", its R&D cost is an important basis for the company’s sales pricing in the US market. The important cost data is corporate trade secrets, and the R&D investment data has not been disclosed.

The total R&D investment of the remaining 9 evaluated varieties of Huahai Pharmaceutical is 44.08 million.

Among them, valsartan tablets have the largest R&D investment of 16.6 million, followed by donepezil hydrochloride tablets with 9.25 million R&D investment.

(Source: Cyberblue)

Unacon: Both are the first enterprises that have been appraised.

According to the statistics of Cybertron, Unacon has passed 7 product specifications and 5 varieties.

Unacon’s semi-annual report shows that the company has been actively promoting consistency evaluation. At the same time, make full use of the opportunity brought by consistency evaluation, strive for greater market share for products, and establish strategic cooperation with core distributors to expand and sink the terminal market to primary medical institutions.

Unacon didn’t disclose its R&D expenses, but according to the statistics of Cybertron, all the evaluated varieties in Unacon were "enterprises that passed the conformity evaluation for the first time".

Metformin hydrochloride: According to the data, metformin, as the most widely used oral hypoglycemic agent in clinic, has been crowned as the "magic medicine". Therefore, according to the statistics of Medical Rubik’s Cube, as a 289 variety, there are as many as 130 drug approval numbers for metformin, including 116 metformin hydrochloride tablets, 8 metformin hydrochloride enteric-coated tablets, 4 metformin hydrochloride enteric-coated capsules and 2 metformin hydrochloride capsules. The consistency evaluation of metformin is bound to be a "drama".

Among them, Unacon submitted its domestic listing application on the condition of "listing in the United States". On July 24th, Unacon’s metformin hydrochloride tablets obtained the registration approval of CFDA, and were officially approved for listing, taking the lead in evaluating the consistency of metformin.

Paclitaxel for injection (albumin-bound): In July, Paclitaxel for injection (albumin-bound) produced in Unacon (trade name Ke Aili) has been included in the Catalogue of Listed Drugs in China. Ke Aili has completed the clinical BE test before applying for new drug registration, and it is deemed to have passed the consistency evaluation, so it can be used instead of the original research product. In this declaration, Unacon surpassed Hengrui, who is known as the "First Brother in R&D", and won the first imitation.

Captopril Tablets: On July 3rd, Captopril Tablets (25mg) produced by Unacon Ouyi Pharmaceutical Company passed the evaluation of the consistency of generic drug quality and efficacy. Unacon Ouyi Pharmaceutical Co., Ltd. became the first enterprise to pass the consistency evaluation of Captopril tablets.

Tramadol Hydrochloride Tablets: On May 21st, Unacon announced that the group’s "Chimet" (tramadol Hydrochloride Tablets (50mg)) has been approved by china food and drug administration to pass the consistency evaluation of generic drug quality and efficacy, becoming the first enterprise in China to pass the consistency evaluation of this variety. It is reported that tramadol Hydrochloride Tablets are one of the key products of the group’s analgesic drugs.

Azithromycin tablets: On April 12th, Unacon announced that the group "Weihong" (azithromycin tablets (0.25g and 0.5g)) had passed the consistency evaluation of generic drugs, becoming the first enterprise in China to pass the consistency evaluation. It is reported that azithromycin tablets are one of the key products of the group’s anti-infective drugs.

Yangzijiang Pharmaceutical: Sustained efforts in mid-2018

Up to now, according to the statistics of Cybertron, seven specifications and five varieties of Yangzijiang Pharmaceutical have passed the consistency evaluation, among which five varieties of amlodipine besylate tablets, montmorillonite powder, glimepiride tablets, enalapril maleate tablets and dexmedetomidine hydrochloride injection have been evaluated.

In the carding process, Ceibaran found that all the remaining varieties passed the consistency evaluation from June to September 2018 except Enalapril Maleate Tablets which were reviewed in September 2017, and Yangzijiang Pharmaceutical continued to exert its strength and continuously reviewed in mid-2018.

(Source: Cyberblue)

From this, it can be seen that the style of Yangzijiang Pharmaceutical Co., Ltd. is to accumulate wealth and make thin hair. At a certain stage, it will exert its strength and continuously evaluate many varieties. When the 289 deadline is coming, Yangzijiang may be accumulating strength and making a big move, which is worth looking forward to.

To sum up, 42 enterprises have varieties that have passed the consistency evaluation, among which Huahai Pharmaceutical, Unacon Pharmaceutical and Yangzijiang Pharmaceutical are the top three, followed by Hengrui Pharma Pharmaceutical, Jingxin Pharmaceutical, Haosen Pharmaceutical and Zhengda Tianqing, and the deadline of 289 is coming soon. All pharmaceutical companies should pay close attention to it.

Publicity of the bid-winning result of security outsourcing service project in financial outlets of Tongchuan Branch

(TenderNo.: SY2025-37/XBMH2025-076)

A, the winning bidder information:

Bid (package) [001] Security outsourcing service project of financial outlets of Tongchuan Branch:

中标人： 陕西京武保安服务有限公司(主供应商）?xa0;?xa0;  其他类型中标价：单价报价

中标人： 陕西汇丰保安服务有限公司（备选供应商）  其他类型中标价：单价报价

二、其他：

（一）陕西京武保安服务有限公司(主供应商）投标单价报价：8.4 元/工时，服务期：2 年。 （二）陕西汇丰保安服务有限公司（备选供应商）投标单价报价：8.43 元/工时，服务期：2 年.

三、监督部门

本招标项目的监督部门为中国邮政集团有限公司陕西省分公司纪委办公室。

四、联系方式

招 标 人：中国邮政集团有限公司陕西省分公司

地?xa0;  址：陕西省西安市高新区唐延路 5 号陕西省邮政大厦 联 系 人：文琰童

电?xa0;  话：029-88602048 电子邮件：/

招标代理机构：陕西西北民航工程咨询有限公司

地?xa0;  址： 西安市唐延路 3 号唐延国际中心 AB 座 8/9 层

联 系 人： 佘冰霞、张恒

电?xa0;  话： 029-88347987-8046

电子邮件： 745496892@qq.com

1905 movie network news Last weekend (12.22-12.24), the box office revenue in North America totaled $169 million, down 38.9% from the previous week. Disney’s strong trump card "Star Wars 8: The Last Jedi Knight" continued to win the weekend box office list with $68.64 million, but compared with the previous week, it suddenly dropped by 68.8%, which was a bit surprising. Fortunately, its own box office base is, and now the local box office has reached 365 million US dollars, and the global box office has reached 745 million US dollars. It is expected that there will be another good-looking "soaring" after the subsequent opening of paintings in mainland China.

In terms of new films, Dwayne Douglas Johnson starred in the highest box office, earning $50.6 million in 3,765 cinemas in five days. There are emotional blessings in word of mouth, but it is also very stable, and it is considered to be entertaining, so it is good to grasp the balance between comedy and action. As the final part, it can’t compare with the brilliance of the second part. It only got $20.45 million in 3,447 cinemas in three days over the weekend, and it was evaluated as "out of tune"! The box office of Hugh Jackman’s musical films is weak, with a total box office of $13.19 million in five days. The evaluation is seriously polarized. Those who like it think it is "full of sincerity" and "perfect and passionate", while those who don’t love it accuse it of being empty. Directed by alexander payne and starring Matt Damon, they also failed to make a difference, earning $4.6 million at the box office in three days, and receiving a moderate evaluation: "I don’t feel the fullness of the story itself". Small-scale screening won $495,000 in nine theaters in three days, with an average box office of 55,000 in a single theater, which was relatively mediocre, but the media evaluation was well maintained. From the short comments, most American media expressed their preference for Steven Allan Spielberg’s brand and basically praised its "practical significance".

Stills of "Brave Game"

"The Brave Game" is full of emotional skills. "Perfect Tone 3" is out of tune.

Recommended star rating for Brave Game: ★★★

"Perfect Tone 3" recommended interstellar: ★★★

"Father Image" recommended Star: ★★★

Sony Colombia "played" 34 million dollars in 3,765 cinemas for three days on the weekend, and the total box office for five days (the film opened last Wednesday) was 50.6 million dollars. Dwayne Douglas Johnson came out of the gloom of its earlier fiasco, which can be compared with the same period in 2007 (the first week’s box office was 44.78 million US dollars, and the final domestic box office was 219 million US dollars). At present, the word-of-mouth is very strong. If this trend continues, the final domestic box office of Game of the Brave: Battle of the Jungle is expected to reach 175 million US dollars. The film is a sequel to robin williams’s classic The Brave Game in 1995. The production cost is 90 million US dollars, and now the global box office has exceeded 100 million US dollars. It is likely to become Sony’s highest-grossing film in China except 007 and Spider-Man series, and the global box office will also become a rare "highlight" after 2015.

The movie Game of the Brave: Battle of the Jungle scored 7.2 in IMDb, 58 in MTC, 77% in freshness of rotten tomatoes, and 89% in audience. "International Screen" commented: "It is entertaining, fascinating, bright in color, ingenious in action and adventure rhythm, and well-arranged in comedy effect." Hollywood Reporter: "The most attractive thing about this film is that you can watch familiar actors pretend to be ordinary children and try to adapt to this new self." Vanity Fair holds that: "Movies can strike a balance between action and comedy. Action design serves the plot, and it is not too flashy. The special effects have also distanced themselves from the previously shoddy monkeys. The comedy elements are cleverly rooted in the characters themselves, and they are not cheap to imitate and follow fixed patterns." Some media that don’t like it, such as Variety, spit out: "This is like watching the worst, except that there is no Indiana Jones."

Universal’s Perfect Tone 3 earned $20.45 million in 3,447 theaters in three days on the weekend, which is completely inferior to the $69 million in the first week. If it can be suppressed first and then promoted like that ($75 million in the first six days and $270 million in the final box office), the final box office is expected to reach $150 million. If it’s really the last movie, it’s still a good ending. From the word of mouth, the media and fans also hope that "Perfect Tone 4 or 5" will not disturb people’s peace again. The movie Perfect Tone 3 now has an IMDb score of 6.1, an MTC score of 40, and the freshness of rotten tomatoes is 29%. "Empire" magazine thinks: "Compared with the jokes in the first two films, it is much weaker, so it drags on to a warm-hearted ending. But it’s all right to end the trilogy like this. After all, it has already started to be framed in fantasy. "International Screen" thinks: "This film finally realizes how ridiculous it is. All the cheerful and stupid plot settings are mostly to make them smoothly transition to the next song or dance. It is hard not to feel the hardship of this film." Hollywood Reporter: "No matter how charming the first two movies are (mainly because of the charm of the leading role), they have lost their charm in this soulless sequel." Chicago Sun: "In a nutshell, Perfect Tone 3 is like a comeback show that no one calls encore."Seattle Times: "It’s just the same movie going back and forth. Is it going to be over until everyone dies?" The Los Angeles Daily directly said: "Out of tune!"

Warner Bros., this year’s big winner, released another film "Father’s Image" near the end of the year, which earned 3.2 million dollars in 2,902 cinemas in three days on weekends. At present, the IMDb score of Father Image is 5.4, the MTC score is 23, and the freshness of rotten tomatoes is 22%. "Hollywood Reporter" thinks: "The whole narrative is from one encounter to the next. In fact, the image of the father doesn’t need to exist at all. If it has to appear, it can actually be developed into a Netflix series by a more comic star, and each suspicious father will talk for half an hour." San Francisco Chronicle: "Such a flawed film is simply not worth two hours." In fact, a lot of bad word-of-mouth has flowed out before the release. It can only be said that Warner’s market is doing too well, and many ordinary fans are still "laughing" with joy.

Next page:The King of Circus and Narrowing Life are mediocre, and Washington post has strong practical significance.

　　[Review last week]

　　Hong Kong stocks performed strongly in early trading last Friday, but the bulls failed to hold their advantage in the afternoon. The Hang Seng Index closed down 0.59, and the Hang Seng Science and Technology Index rose nearly 2% in early trading, and the closing increase narrowed to 0.29%.

　　On the disk, JD.COM Q1′ s performance was bright, and its share price rose over 7%, leading the strength of weighted technology stocks; Film and television entertainment stocks, power stocks and mobile game stocks rose.

　　On the other hand, the price of gold fell at a high level, and the non-ferrous metal plate fell; Collective adjustment of the concept stocks of China Special Appraisal Company.

　　[capital flow]

　　Last Friday, southbound funds sold a net of HK$ 235 million. SMIC ranked first in net purchases and first in net sales.

　　Short-selling data are as follows:

　　[breaking news]

　　90% of employees over the age of 35 are laid off? Xiaomi responded: rumors

　　Recently, some netizens posted on social media: "The second headquarters of a certain meter in Wuhan officially announced that 90% of employees over the age of 35 will be laid off." This statement quickly fermented on the Internet, and some netizens speculated that it was Xiaomi Group.

　　In response to the above rumors, Wang Hua, general manager of the public relations department of Xiaomi Group, responded in Weibo on May 14th. "Last night, there were reports on social media platforms that employees over 35 years old in our Wuhan headquarters only kept 10% of the information, which were all rumors after investigation. Now the legal department of the company has obtained evidence for relevant information and reported it to relevant departments. "

　　Xu Jiayin became the executor.

　　On the evening of May 12th, China Evergrande announced that it had received an enforcement notice from the Guangzhou Intermediate People’s Court on the arbitration award of Shenzhen International Arbitration Court. The Company, its subsidiary "Guangzhou Kailong Real Estate" and the executive director Xu Jiayin are the executors of the enforcement notice. According to the execution notice, the items to be executed are:

　　(1) Guangzhou Kailong and Mr. Xu paid the balance of dividends of Evergrande Real Estate in 2020 to make up about RMB 204 million, and assumed the liquidated damages of about RMB 51.53 million;

　　(2) Mr. Xu and the company bought back the equity of Evergrande Real Estate held by the arbitration applicant for RMB 5 billion;

　　(3) The compensation paid by the company to the arbitration applicant from February 1, 2021 to the completion of the repurchase is about RMB 770 million;

　　(4) The Company, Guangzhou Kailong and Mr. Xu paid about RMB 35.53 million in legal fees, arbitration fees and execution fees.

　　The total valuation of 47 projects of Evergrande Auto 2 yuan "Sale" exceeds 60 billion.

　　On May 12th, Evergrande announced that the shareholders’ meeting had agreed to sell its 47 real estate projects to China Evergrande and its subsidiaries. This means that Evergrande has completed the divestiture of real estate business and focused on the new energy vehicle business. Evergrande Automobile will concentrate resources to fully guarantee the R&D and production of Hengchi.

　　According to the announcement, the two parties signed an agreement to transfer all the issued shares of Huibao and Flaming Ace under Evergrande Automobile, covering 47 existing health space projects of Evergrande Automobile Group, including 21 Evergrande Health Valley projects, 5 Evergrande Health City projects and 21 various property development projects.

　　After the completion of the sale, Evergrande no longer holds any rights and interests of the above two companies, and it is estimated that it will record a sale income of about 24.789 billion yuan.

　　According to the unaudited data provided by Evergrande Automobile, as of December 31, 2022, the net liabilities of projects such as Health Valley to be sold were 24.789 billion yuan, and the project valuation was about 60.1 billion yuan. In 2022, its income was only about 1.5 billion yuan, and its net loss after tax reached 8.824 billion yuan.

　　Large shareholder clearance and evacuation? Vida International Emergency Response

　　Recently, there is market news that the Swedish company Essity, the controlling shareholder of Vida International, announced that it is considering selling the shares of Vida International; Fuan International, controlled by Li Chaowang, the second largest shareholder and chairman of the board of directors of Vida International, intends to acquire Essity.

　　On May 14th, Vader International published a voluntary announcement, saying that the Board of Directors had not received any latest information about the review of Essity strategy.

　　[Company News]

　　1. (): In the first four months, the accumulated original premium income was 108.343 billion yuan and 71.543 billion yuan respectively through Taiping Life Insurance and Pacific Property Insurance, which decreased by 2.9% and increased by 16.0% respectively.

　　2. Ping An in China: In the first four months, the premium income of the original insurance contract was about 100.459 billion yuan, 208.185 billion yuan, 8.214 billion yuan and 5.849 billion yuan respectively through Ping An Property Insurance, Ping An Life Insurance Company of China, Ping An Endowment Insurance and Ping An Health Insurance, totaling about 322.707 billion yuan, up 5.93% year-on-year.

　　3. Baekje Shenzhou: The revenue in the first quarter was 3.066 billion yuan, a year-on-year increase of 57.4%; During the period, the total product revenue was about 2.808 billion yuan, a year-on-year increase of 69%; The net loss attributable to shareholders was about 2,446.6 million yuan, a year-on-year decrease of 14.64%. Mainly due to the sales growth of self-developed products and authorized products.

　　4. (): The subsidiary plans to invest 2.5 billion yuan to build a new energy lithium battery production research and development project in Xiangyang.

　　5. (): It is planned to invest in a new battery-grade lithium hydroxide production base project with an annual output of 30,000 tons in Zhangjiagang Free Trade Zone, with an estimated annual income of not less than 2 billion yuan.

　　6. R&F Property: In the first four months, the accumulated contracted sales were 9.02 billion yuan, down 49.18% year-on-year, of which the contracted sales in April were 1.66 billion yuan, down 61.12% year-on-year.

　　7. Hejing Taifu Group: The contracted sales in April was 3.231 billion yuan, a year-on-year decrease of 25.8%; The sales area was 144,000 square meters, a year-on-year decrease of 29.8%.

　　8. Good Boy International: Revenue in the first quarter decreased by 17.5% year-on-year to about HK$ 1.842 billion, and decreased by 14% year-on-year in terms of constant currency.

　　9. CGNPC New Energy: The subsidiary intends to sell all the shares of Nantong Meiya, and the initial public bidding price is about 420 million yuan.

　　[repurchase dynamics]

　　1. AIA: It spent about HK$ 132 million to buy back 1.652 million shares at a repurchase price of HK$ 79.55-81.3.

　　2. HSBC Holdings: It spent about HK$ 147 million to repurchase 2.5 million shares at a repurchase price of HK$ 58.40-58.95.

　　3. (): Chongqing Water Investment Group increased its holdings of 35.0092 million A shares, with a total shareholding ratio of 7.013%.

　　4. (): It is planned to buy back 1.5 billion to 3 billion yuan of A shares for the implementation of the company’s employee stock ownership plan.